TITLE

THE PHYSIOLOGIC ENZYMES ACTIVATING PROFIBRINOLYSIN TO FIBRINOLYSIN, AND THE SUBSTANCES WHICH INHIBIT ACTIVATION

AUTHOR(S)
Misirlioglu, Yusuf I.; Walton Lillkhei, C.
PUB. DATE
May 1962
SOURCE
Angiology;May1962, Vol. 13 Issue 5, p185
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a discussion related to the physiologic enzymes activating profibrinolysin to fibrinolysin, and the substances which inhibit activation. The discovery of phosphatases as the main activator of profibrinolysin to fibrinolysin, with coenzymes, will have many fold applications. They are an additional physiologic factor which helps to maintain the fluidity of the blood in the blood vessels, and prevent coagulation as long as the intimal layer is intact. The phosphatases can be utilized as an anticoagulant.
ACCESSION #
16370322

 

Related Articles

  • Streptokinase as Fibrinolytic Agent. Hamid, Mohsina; Khalil-Ur-Rehman; Asghar, Muhammad; Sarwar, Muhammad // Asian Journal of Chemistry;2012, Vol. 24 Issue 4, p1809 

    Accumulation of fibrin in the blood vessels usually results in the thrombosis, leading to myocardial infarction and other cardiovascular diseases. For thrombolytic therapy microbial fibrinolytic enzymes have now attracted much more attention than typical thrombolytic agents because of the high...

  • Plasminogen-related.  // Encyclopedic Reference of Cancer;2001, p701 

    A definition of the term "plasminogen-related protein" is presented. It refers to a protein that shares structural similarity and evolutionary relationship with plasminogen.

  • Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy. Zubac, Dragomir P.; Wentzel-Larsen, Tore; Seidal, Tomas; Bostad, Leif // BMC Urology;2010, Vol. 10, p20 

    Background: To examine the expression of type 1 plasminogen inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC), and its possible association with microvessel density (MVD), the expression of thrombospondin-1 (TSP-1), nuclear grade, tumour stage, continuously coded tumour size (CCTS)...

  • Renal fibrosis: not just PAI-1 in the sky. Fogo, Agnes B. // Journal of Clinical Investigation;Aug2003, Vol. 112 Issue 3, p326 

    Presents a commentary on a study which demonstrated that therapy with a mutant plasminogen activator inhibitor-1 (PAI-1) increases matrix turnover and reduces glomerusclerosis. Result that occurs from progressive fibrosis; Factor linked to the efficacy of angiotensin I-converting enzyme...

  • The effects of whole body vibration and exercise on fibrinolysis in men. Boyle, Leryn J.; Nagelkirk, Paul R. // European Journal of Applied Physiology;Nov2010, Vol. 110 Issue 5, p1057 

    Whole body vibration (WBV) is a novel modality that has been demonstrated to enhance muscular and cardiovascular functions reported to increase fibrinolytic activity. The purpose of this study was to examine the fibrinolytic response to WBV and exercise in men. Twenty healthy males (23.8 ±...

  • Yeast mannan in combination with high concentration of Ca2+ enhances production of tissue plasminogen activator by human diploid fibroblasts stimulated with proteose peptone. Itagaki, Yasuharu // Biotechnology Letters;Jan2002, Vol. 24 Issue 2, p103 

    The efficient production of tissue plasminogen activator by human diploid fibroblasts is described. Confluent fibroblasts lost their tissue plasminogen activator-producing ability when incubated in a serum-free control medium containing proteose peptone (10 mg ml-1) for longer than 4 to 7 d. In...

  • Acoustic determination of performance and equivalence of plasminogen activators. Ghazali, Mirnader; Hayward, Gordon L. // Analytical & Bioanalytical Chemistry;Nov2008, Vol. 392 Issue 5, p897 

    A reliable method for the measurement of different plasminogen activators is of great interest for both manufacturing and clinical medicine. A one-step assay based on a thickness shear mode acoustic sensor has been developed for this purpose. Two separate mixtures of substrates (fibrinogen and...

  • Neuroimaging: Current Challenges, Future Trends. Buckley, Rita // MD Conference Express; 

    The article focuses on the Diffusion-Weighted Imaging Evaluation for Understanding Stroke Evaluation Study 2 (DEFUSE-2). The result of the study showed that diffusion and perfusion-weighted imaging (DWI/PWI) can identify subgroups with a differential response to reperfusion following intravenous...

  • The Plasminogen Activator Inhibitor-1 Gene Is Induced by Cell Adhesion through the MEK/ERK Pathway. Hang Chang; Kou-Gi Shyu; Shankung Lin; Shiow-Chwen Tsai; Bao-Wei Wang; Ya-Chen Liu; Yu-Ling Sung; Chun-Chung Lee // Journal of Biomedical Science;Nov/Dec2003, Vol. 10 Issue 6, p735 

    The type-I plasminogen activator inhibitor (PAI-1), the primary inhibitor of both tissue-type and urokinase-type plasminogen activators (t-PA, u-PA), is the primary regulator of plasminogen activation and possibly of extracellular proteolysis. In anchorage-dependent cells, the PAI-1 gene is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics